![Nancy Thornberry](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Nancy Thornberry
Direktor/Vorstandsmitglied bei
SCHRÖDINGER, INC.
Vermögen: 2 Mio $ am 31.05.2026
Profil
Nancy A. Thornberry is the founder of Kallyope, Inc., founded in 2014, where the title held is Director.
Current jobs include Independent Director at Vertex Pharmaceuticals, Inc. since 2023, Independent Director at Schrödinger, Inc. since 2019, Director at New York Genome Center, Independent Director at Denali Therapeutics, Inc. since 2021, Scientific Advisor at Hatteras Venture Partners, and Advisor at GV Management Co. LLC.
Former jobs include Director at Abide Therapeutics, Inc., Director at Intarcia Therapeutics, Inc., Senior VP, Head-Diabetes & Endocrinology at Merck & Co., Inc. from 2011 to 2013, and Principal at Merck Research Laboratories Massachusetts LLC.
Education includes undergraduate studies at Muhlenberg College.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 01.05.2026 | 2 109 ( 0 % ) | 943 862 $ | 31.05.2026 | |
DENALI THERAPEUTICS INC. 0,02 % | 03.06.2026 | 31 125 ( 0,02 % ) | 654 870 $ | 31.05.2026 |
SCHRODINGER, INC. 0,04 % | 22.06.2026 | 25 388 ( 0,04 % ) | 385 898 $ | 31.05.2026 |
Aktive Positionen von Nancy Thornberry
| Unternehmen | Position | Beginn |
|---|---|---|
| SCHRÖDINGER, INC. | Direktor/Vorstandsmitglied | 24.09.2019 |
| DENALI THERAPEUTICS INC. | Direktor/Vorstandsmitglied | 08.01.2021 |
| VERTEX PHARMACEUTICALS INCORPORATED | Direktor/Vorstandsmitglied | 05.12.2023 |
Kallyope, Inc.
 Kallyope, Inc. BiotechnologyHealth Technology Engages in discovering and developing of novel, neurological and metabolic therapeutics | Gründer | 01.01.2014 |
GV Management Co. LLC
 GV Management Co. LLC Investment ManagersFinance Google Ventures invests in companies located in North America, Europe and Israel. The firm focuses on companies operating in the fields of technology and life sciences sectors. It provides financing for seed, early and growth stage capital requirements. | Berater | - |
Hatteras Venture Partners
 Hatteras Venture Partners Investment ManagersFinance Hatteras Venture Partners invests in companies located in the United States. The firm targets companies operating in the fields of biopharmaceuticals, medical devices, diagnostics, healthcare IT and human medicine. It provides financing for seed and early stage capital requirements and also makes co-investments. | Berater | - |
New York Genome Center
 New York Genome Center Miscellaneous Commercial ServicesCommercial Services Provides genomic research services | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Nancy Thornberry
| Unternehmen | Position | Ende |
|---|---|---|
| MERCK & CO., INC. | Corporate Officer/Principal | 01.07.2013 |
Merck Research Laboratories Massachusetts LLC
 Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products | Corporate Officer/Principal | - |
| ░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
Ausbildung von Nancy Thornberry
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
74
Beziehungen ersten Grades
12
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 12 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Vertex Pharmaceuticals, Inc.
 Vertex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops drugs for the treatment of cystic fibrosis | Health Technology |
Abide Therapeutics, Inc.
 Abide Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company intended to develop drugs for serious diseases | Health Technology |
Muhlenberg College
 Muhlenberg College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Intarcia Therapeutics, Inc.
 Intarcia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops innovative therapies utilizing the Medici drug delivery system | Health Technology |
Schrödinger, Inc.
 Schrödinger, Inc. Packaged SoftwareTechnology Services Develops physics-based software platform which enables discovery of novel molecules for drug development and materials applications | Technology Services |
Hatteras Venture Partners
Hatteras Venture Partners Investment ManagersFinance Hatteras Venture Partners invests in companies located in the United States. The firm targets companies operating in the fields of biopharmaceuticals, medical devices, diagnostics, healthcare IT and human medicine. It provides financing for seed and early stage capital requirements and also makes co-investments. | Finance |
Merck Research Laboratories Massachusetts LLC
Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products | Health Technology |
GV Management Co. LLC
GV Management Co. LLC Investment ManagersFinance Google Ventures invests in companies located in North America, Europe and Israel. The firm focuses on companies operating in the fields of technology and life sciences sectors. It provides financing for seed, early and growth stage capital requirements. | Finance |
New York Genome Center
New York Genome Center Miscellaneous Commercial ServicesCommercial Services Provides genomic research services | Commercial Services |
Denali Therapeutics, Inc.
 Denali Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutics for neurodegenerative diseases | Health Technology |
Kallyope, Inc.
Kallyope, Inc. BiotechnologyHealth Technology Engages in discovering and developing of novel, neurological and metabolic therapeutics | Health Technology |
